1-7 of 7
Silvia Locatelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longitudinal Assessment of Circulating Tumor Mutational Burden Using a Next-Generation Sequencing Cancer Gene Panel: A Potential Biomarker of Response to Programmed Cell Death 1 (PD-1) Blockade in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma

Martina Di Trani, Ettore Rizzo, Silvia Locatelli, PhD, Fabrizio Marino, MD, Vanessa Cristaldi, PhD, Valeria Spina, PhD, Alessio Bruscaggin, PhD, Federica De Paoli, PhD, Giuseppa Careddu, Marcello Rodari, MD, Margarita Kirienko, MD, Eleonora Calabretta, MD, Massimo Magagnoli, MD, Lucia Morello, MD, Francesca Ricci, MD, Arturo Chiti, MD, Armando Santoro, Stefan Hohaus, MD, Davide Rossi, MD PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 131.
https://doi.org/10.1182/blood-2019-131096
Published: 2019
Journal Articles

A Novel and Potent Inhibitor of E-Selectin, GMI-1687, Attenuates Thrombus Formation and Augments Chemotherapeutic Intervention of AML in Preclinical Models Following Subcutaneous Administration

John Peterson, PhD, Myung-Gi Baek, PhD, Silvia Locatelli-Hoops, PhD, Ji-Won Lee, PhD, Lingquan Deng, PhD, David A Stewart, Theodore AG Smith, PhD, Daniel Durant Myers, DVM, MPH, William E Fogler, PhD, John L Magnani, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4678.
https://doi.org/10.1182/blood-2018-99-116779
Published: 2018
Journal Articles

A Novel Glycomimetic Compound (GMI-1757) with Dual Functional Antagonism to E-Selectin and Galectin-3 Demonstrates Inhibition of Thrombus Formation in an Inferior Vena Cava Model

John Peterson, PhD, Yusuf Vohra, PhD, Daniel Durant Myers, DVM, MPH, Silvia Locatelli-Hoops, PhD, Ji-Won Lee, PhD, Lingquan Deng, PhD, Theodore AG Smith, PhD, William E Fogler, PhD, John L Magnani, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2211.
https://doi.org/10.1182/blood-2018-99-118122
Published: 2018
Journal Articles

Genotyping of Classical Hodgkin Lymphoma on the Liquid Biopsy

Valeria Spina, PhD, Alessio Bruscaggin, PhD, Annarosa Cuccaro, Maurizio Martini, MD PhD, Martina Di Trani, Gabriela Forestieri, Martina Manzoni, Luca Nassi, Adalgisa Condoluci, Alberto Arribas, PhD, Silvia Locatelli, Elisa Cupelli, Luca Ceriani, Alden Moccia, Anastasios Stathis, MD, Clara Deambrogi, PhD, Fary Diop, Francesca Guidetti, Antonino Neri, MD, Bernhard Gerber, MD, Francesco Bertoni, MD, Michele Ghielmini, MD, Georg Stuessi, MD, Armando Santoro, MD, Franco Cavalli, MD, Emanuele Zucca, MD, Luigi Maria Larocca, MD, Gianluca Gaidano, MD PhD, Stefan Hohaus, Carmelo Carlo-Stella, MD, Davide Rossi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 307.
https://doi.org/10.1182/blood.V130.Suppl_1.307.307
Published: 2017
Journal Articles

Phosphorylation Levels of Extracellular-Signal Regulated Kinase (ERK) and AKT in Circulating Lymphocytes Predict Response to Targeted Therapy with Kinase Inhibitors in Refractory/Relapsed Hodgkin Lymphoma Patients,

Anna Guidetti, MD, Silvia Locatelli, PhD, Simonetta Viviani, MD, Anna Dodero, MD, Lucia Farina, MD, PhD, Domenico Russo, Pietro Bulian, Roberto Sorasio, MD, Massimo Di Nicola, MD, Paolo Corradini, MD, Andrea Anichini, PhD, Alessandro M. Gianni, MD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2011) 118 (21): 3705.
https://doi.org/10.1182/blood.V118.21.3705.3705
Published: 2011
Journal Articles

Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma

Silvia Locatelli, PhD, Arianna Giacomini, PhD, Anna Guidetti, MD, Loredana Cleris, PhD, Michele Magni, MD, Massimo Di Nicola, MD, Roberta Mortarini, PhD, Alessandro M Gianni, MD, Andrea Anichini, PhD, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2011) 118 (21): 1653.
https://doi.org/10.1182/blood.V118.21.1653.1653
Published: 2011
Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Marco Ruella, MD, Rosalba Miceli, MD, Liliana Devizzi, MD, Daniela Sia, PhD, Silvia Locatelli, PhD, Arianna Giacomini, PhD, Michele Magni, MD, Paola Matteucci, MD, Stefano Buttiglieri, PhD, Alessandra Risso, PhD, Luigi Mariani, MD, Roberto Passera, PhD, Massimo Di Nicola, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2010) 116 (21): 1289.
https://doi.org/10.1182/blood.V116.21.1289.1289
Published: 2010